OOIR: Observatory of International Research

Papers

(The median citation count of Personalized Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
The role of circular RNAs in therapy resistance of patients with solid tumors	35
A review of clinical pharmacogenetics Studies in African populations	34
The evolution of personalized healthcare and the pivotal role of European regions in its implementation	29
Assessment of healthcare professionals’ knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt	28
Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls	27
Review of policies of companies and databases regarding access to customers’ genealogy data for law enforcement purposes	22
Elevated expression of ASF1B correlates with poor prognosis in human lung adenocarcinoma	17
International consortium for personalized medicine: an international survey about the future of personalized medicine	17
Increase inMEG3, MALAT1, NEAT1significantly predicts the clinical parameters in patients with rheumatoid arthritis	14
The United States 2020 Census data: implications for precision medicine and the research landscape	14
Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection	13
Gout prevalence in the Hmong: a prime example of health disparity and the role of community-based genetic research	12
Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resection	12
Artificial intelligence in healthcare: a primer for medical education in radiomics	11
MiR-452-5p mediates the proliferation, migration and invasion of hepatocellular carcinoma cells via targeting COLEC10	11
Promoter region single nucleotide polymorphism of siglec-8 gene associates with susceptibility to allergic asthma	10
Engaging community stakeholders in research on best practices for clinical genomic sequencing	9
Creating accessible Spanish language materials for Clinical Sequencing Evidence-Generating Research consortium genomic projects: challenges and lessons learned	8
Public interest in whole genome sequencing and information needs: an online survey study	8
Clinical validity of a gene expression signature in diagnostically uncertain neoplasms	8
Intelligent health system for the investigation of consenting COVID-19 patients and precision medicine	8
Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review	8
Personalized medicine in Latin America	8
Clinical significance and functions of miR-203a-3p/AVL9 axis in human non-small-cell lung cancer	8
Predictive role of single nucleotide polymorphism (rs11614913) in the development of breast cancer in Pakistani population	7

CYP2D6 does not impact on breast cancer-free survival in Southeast Mexican patients under tamoxifen treatment	7
Concentration and integrity indexes of urine cell-free DNA as promising biomarkers for early lung cancer diagnosis	7
The frequency of majorCYP2C19genetic polymorphisms in women of Asian, Native Hawaiian and Pacific Islander subgroups	7
Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology	7
LncRNA ZFAS1, as a poor prognostic indicator, promotes cell proliferation and epithelial–mesenchymal transition in endometrial carcinoma	7
Recommendations to researchers for aiding in increasing American Indian representation in genetic research and personalized medicine	7
Toward precision health: applying artificial intelligence analytics to digital health biometric datasets	7
Clinician perspectives on communication and implementation challenges in precision oncology	7
Correlation of miR-600 with WT1 expression and its potential clinical significance in breast cancer	6
miR-516a-3P, a potential circulating biomarker in hepatocellular carcinoma, correlated with rs738409 polymorphism in PNPLA3	6
Clinical significance of serum miR-101-3p expression in patients with neonatal sepsis	6
Nudges and the meaningful adoption of digital health	6
The role of miR-101 in esophageal and gastric cancer	6
Stem cells as therapeutic targets in colorectal cancer	6
Assessing the implications of positive genomic screening results	6
MiR-455-5p serves as a biomarker of atherosclerosis and inhibits vascular smooth muscle cell proliferation and migration	6
The enduring importance of family health history in the era of genomic medicine and risk assessment	5
Nutrigenetics and nutrigenomics: ready for clinical use or still a way to go?	5
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine	5
Expanded carrier screening in Flanders (Belgium): an online survey on the perspectives of nonpregnant reproductive-aged women	5
Family-level impact of genetic testing: integrating health economics and ethical, legal, and social implications	5
‘It’s much more grey than black and white’: clinical geneticists’ views on the oversight of consumer genomics in Europe	5
Defining the role of pharmacists in medication-related genetic counseling	4
Mini-gut feelings: perspectives of people with cystic fibrosis on the ethics and governance of organoid biobanking	4
Prioritizing pharmacogenomics implementation initiates: a survey of healthcare professionals	4
Association study of genetic polymorphisms inGABRDwith treatment response and dose in methadone maintenance treatment	4
Alignment of health plan coverage policies for somatic multigene panel testing with clinical guidelines in select solid tumors	4
Views on genomic research result delivery methods and informed consent: a review	4
PON1 polymorphisms can predict generalized anxiety and depressed mood in patients with multiple chemical sensitivity	4
Association ofPON-1polymorphism with susceptibility to and severity of ischemic stroke in the Chinese population	3
Personalized therapy: can it tame the COVID-19 monster?	3
Guanylyl cyclase C as a diagnostic and therapeutic target in colorectal cancer	3
Budget impact and transferability of cost–effectiveness of DPYD testing in metastatic breast cancer in three health systems	3
SARS-CoV-2 variant identification using a genome tiling array and genotyping probes	3
Positive association of SCD1 genetic variation and metabolic syndrome in dialysis patients in China	3
Role of precision nutrition in improving military performance	3
An international genomics health workforce education priorities assessment	3
miR-938 rs2505901 T>C polymorphism increases Hirschsprung disease risk: a case–control study of Chinese children	3
The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites	3
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK	3
Long noncoding RNA polymorphisms and hepatocellular carcinoma and pancreatic cancer risk	3
Healthcare professionals' knowledge, attitudes and future expectations towards personalized medicine	3
Attitudes of Costa Rican individuals towards donation of personal genetic data for research	3
Omics technologies in personalized combination therapy for cardiovascular diseases: challenges and opportunities	3
Rs739837 affects the severity of asthma by disrupting the binding of microRNA-885	3
Personalized medicine in Austria: expectations and limitations	3
Targeting molecular alterations in non-small-cell lung cancer: what's next?	3
Universal tumor screening for lynch syndrome: perspectives of patients regarding willingness and informed consent	3
Application of transcriptomics and proteomics in pulmonary arterial hypertension	3
Cost–effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young	3

The integration of personalized medicine into health systems: progress and a path forward	3
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries	2
From personalized to precision cancer medicine	2
A GRIN3A polymorphism may be associated with glucocorticoid-induced symptomatic osteonecrosis in children with acute lymphoblastic leukemia	2
Predictive value of leukocyte telomere length for the severity of coronary artery disease	2
Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment	2
SKA3, negatively regulated by miR-128-3p, promotes the progression of non-small-cell lung cancer	2
Identification of unique long non-coding RNAs as putative biomarkers for chromophobe renal cell carcinoma	2
Genetic polymorphisms of miRNA machinery genes in bicuspid aortic valve and associated aortopathy	2
A consensus on collaboration: reviewing the 15th Annual Personalized Medicine Conference at Harvard Medical School	2
The role of metabolomics in personalized medicine for diabetes	2
Development and evaluation of an exome sequencing training course for medical interpreters	2
RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center	2
Medical geneticists, genetic diseases and services in Brazil in the age of personalized medicine	2
Investigating underlying human immunity genes, implicated diseases and their relationship to COVID-19	2
Polymorphisms in genes involved in breast cancer among Iranian patients	2
How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?	2
Association of NQO1Pro187Ser polymorphism with clinical outcomes and survival of lung cancer patients treated with platinum chemotherapy	2
miR-369-3p serves as prognostic factor and regulates cancer progression of hepatocellular carcinoma	2
Racial and ethnic minority patient participation in N-of-1 trials: perspectives of healthcare providers and patients	2
Attitudes toward pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention	2
Personalized medicine in lipid-modifying therapy	2
Cost–effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries	2
Big data in severe mental illness: the role of electronic monitoring tools and metabolomics	2
State-of-the-art knowledge on the regulation of advanced therapy medicinal products	2
HER2 in gastric adenocarcinoma: where do we stand today?	1
Seven non-differentially expressed ‘dark biomarkers’ show transcriptional dysregulation in chronic lymphocytic leukemia	1
Texas health educators’ practice in basic genomics education and services	1
Investigation ofDPYD,MTHFRandTYMSpolymorphisms on 5-fluorouracil related toxicities in colorectal cancer	1
Blood direct PCR: impact of CYP2C19 and CYP4F2 variants for bleeding prediction in ST-elevation myocardial infarction patients with ticagrelor	1
Correlation between plasma lncRNA CASC11 and malignancy in lung adenocarcinoma patients and the prognostic value of lncRNA CASC11	1
Deliberations about clinical pharmacogenetic testing in pediatric oncology	1
Challenges and opportunities in building a health economic framework for personalized medicine in oncology	1
The use of molecular biomarker tests: an interview study with healthcare providers about a molecular biomarker test for prostate cancer	1
Genetic predisposition for the development of lamotrigine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis	1
Biomarker-driven immunotherapy for precision medicine in prostate cancer	1
A roadmap for precision medicine research recruitment: empirical assessment of the public's willingness to participate	1
A sociogenomic paradigm to replace the racial paradigm	1
Epithelioid sarcoma as the prototype for personalized therapy in soft tissue sarcoma	1
Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies	1
A precision medicine approach to stress testing using metabolomics and microribonucleic acids	1
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation	1
Therapeutic drug monitoring guided fluconazole therapy in a patient with cholangitis sepsis	1
COVID-19 telehealth preparedness: a cross-sectional assessment of cardiology practices in the USA	1
Developing and validating noninvasive prenatal testing for de novo autosomal dominant monogenic diseases in Vietnam	1
The pharmacogenetics of mycophenolate mofetil in Tunisian renal transplant patients	1
ABCB1 and SLCO1B1 gene polymorphisms predict methotrexate-resistant for low-risk gestational trophoblastic neoplasia	1
Developing new frameworks to value genomic information: accounting for complexity	1
Pharmacogenomic testing for mental health (Part I): documenting early adopter perceptions of use for eight scenarios	1
Avoiding “toxic knowledge”: the importance of framing personalized risk information in clinical decision-making	1
Individualizing pharmacogenomic test results in the context of the microbiome	1
Patient views on genetics and functional imaging for precision medicine: a willingness-to-pay analysis	1
Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the USA	1
Guideline-recommended incorporation of biomarker testing results in metastatic colorectal cancer therapy	1
HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead	1
Prophylactic lymph node dissection in clinically N0 differentiated thyroid carcinoma: example of personalized treatment	1
A personalized approach to pancreatic ductal adenocarcinoma and its application in surgical practice	1